OpenVSafe by OpenVAERS
Search V-safe

GAA-17303-54562

2 vaccinations 1 coded response 5 check-ins 1 free-text entry 0 call cases
Sex
Male
Age at first dose
46-50
ZIP prefix
910 / CA
Registered
2021-09-28
Relationship
Adult relative or friend
Guardian
9WD-72398-34261
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-07-23
    Dose 1 — Pfizer-BioNTech
  2. 2021-08-30
    Dose 2 — Pfizer-BioNTech
  3. 2021-09-28
    Registered in v-safe
  4. 2021-09-28
    Health check-in — day 28, dose 2, dependent
    Feeling: Good
    Adult check-in
  5. 2021-10-04
    Health check-in — day 35, dose 2, dependent
    Feeling: Good
    Adult check-in
  6. 2021-11-30
  7. 2022-03-06
    Survey response — 6 months, dose 2, dependent
    MedDRA: Cough, Hyperhidrosis, Oropharyngeal pain, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Fever, cough, sore throat, sweating
    MedDRA releases: 2024-11 · check-in free text available
  8. 2022-09-02

Vaccinations

DoseDateManufacturerCo-administered
12021-07-23Pfizer-BioNTech No
22021-08-30Pfizer-BioNTech No

Free text

Release 11 — 6 months, dose 2, dependent

2022-03-06

Symptoms: Fever, cough, sore throat, sweating

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDHyperhidrosis · · ✓
SDOropharyngeal pain · · ✓
SDPyrexia · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release